Worldwide Healthcare Trust - Manager suggests May 2022 was inflexion point
Worldwide Healthcare Trust (WWH) has two co-managers, Sven Borho and Trevor Polischuk at global healthcare specialist OrbiMed. Borho recently presented at the WWH AGM and despite disappointing performance in FY22 (March year-end), which he notes was a ‘mirror image’ of FY21, the manager remains optimistic about the trust’s prospects. He is hopeful that May/June 2022 marked the low point in the absolute and relative performance of biotech stocks and is confident that the focus on favouring emerging biotech and emerging market stocks over large-cap pharma companies will once again be the correct strategy for WWH’s shareholders. Borho considers that the trust’s portfolio offers investors a ‘mix of the big guys’, which gives some stability, along with ‘explosive growth’ companies, and this approach has delivered significant outperformance versus WWH’s benchmark over the long term.Worldwide Healthcare Trust is an investment trust. Co. invest in the global healthcare sector particularly in pharmaceutical and biotechnology companies and related securities in the healthcare sector. In addition, Co. invests in medical device technologies, life science tools and healthcare services. A maximum of 20% of the portfolio, at the time of acquisition, may be invested in companies in each of the following sectors: healthcare equipment and supplies; healthcare technology; and healthcare providers and services. Co.'s investment portfolio at Mar 31 2017, principally comprised listed equity investments, OTC swaps and unquoted debt investments and totalled £1,192,881,000.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.